Predeposit autologous blood donation.

Area of Science:

• Transfusion Medicine
• Surgical Patient Care

Background:

• Predeposit autologous donation (PAD) is medically proven safe and effective for elective surgeries with potential transfusion needs.
• PAD offers significant advantages, including the avoidance of transfusion-transmitted diseases and alloimmunization.
• Despite its benefits, PAD is notably underutilized in clinical practice.

Purpose of the Study:

• To highlight the safety and efficacy of predeposit autologous donation.
• To discuss the advantages and essential criteria for donor selection in autologous blood banking.
• To review transfusion criteria and address the unresolved issue of managing unused autologous blood.

Main Methods:

• Review of existing medical evidence on autologous blood donation.
• Analysis of donor selection criteria, including age, weight, and adverse reaction incidence.
• Examination of perioperative transfusion requirements and management strategies, including iron supplementation.
• Discussion of blood storage methods (liquid and frozen) and transfusion criteria.

Main Results:

• Autologous donation is safe and effective, with adverse reaction rates comparable to homologous donors when properly selected.
• Oral ferrous sulfate administration aids patients in meeting perioperative transfusion needs.
• Transfusion criteria for autologous blood are similar to homologous blood, with potential for liberal interpretation.

Conclusions:

• Predeposit autologous donation is a valuable, underutilized resource for elective surgery, enhancing patient safety by preventing transfusion-related risks.
• Appropriate donor selection and patient preparation, including iron supplementation, are crucial for maximizing the benefits of autologous blood.
• Further clarification is needed regarding the optimal disposition of untransfused autologous blood units to maximize resource utilization.